COMP <GO>
FBIO vs CPIX // DIVIDEND YIELD & FCF PAYOUT SAFETY
Fortress Biotech Inc. (NASDAQ) VS. Cumberland Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: FBIO 4
— CPIX 5
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: FBIO
LAST: $1.92 (-4.00%) • MKT CAP: $66.7M
dividend-safety
1.00%
LAST: $4.69 (+7.82%) • MKT CAP: $65.2M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FBIO VS. CPIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FBIO | CPIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.90% | 85.00% | -18.10 | CPIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -16.40% | -18.60 | CPIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 7.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -6.30% | -53.70 | CPIX | /operating-margins <GO> |
| Net Profit Margin | 58.50% | -6.40% | +64.90 | FBIO | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 17.60% | -7.90 | CPIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 1.00% | 0.00% | +1.00 | FBIO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.72 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.7 | 35.3 | +3.44 | FBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $66.7M | $65.2M | $1.5M | FBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FBIO REV | CPIX REV | FBIO GROSS % | CPIX GROSS % | FBIO FCF | CPIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $63.3M | $44.5M | 66.9% | 85.0% | -$65.8M | $4.8M |
| FY 2024 | $57.7M | $37.9M | 63.8% | 82.6% | -$80.2M | -$678.6K |
| FY 2023 | $84.5M | $39.6M | — | — | -$128.2M | $6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FBIO // BETA —
CPIX // BETA —